Preclinical and Tox Formulation Development

Contrary to popular belief, early formulation development is not simply dumping API in a vehicle and gavage feeding an animal.  If you do this, you will most likely lose time and money with unnecessary and confusing PK studies.  This led to the development of our SMART biopharmaceutical solutions that offer input from our scientific advisory board:  A one-stop shop from candidate selection through early development.  


This is an integrated approach to find the right form and formulation every step of the development cycle using decision trees and guidance documents built from our over 80 years of innovative pharmaceutical experience. Using our SMART services will lead to the shortest possible development timelines with limited resource utilization.

shape_pic-13.png Preclinical page graphic1.png

Preclinical and Tox Formulation - Resources

Click to visit resource in a new window. Please check back often for the latest updates. This page will stay open so you can return.